Space is limited - RSVP/Purchase Tickets Below. Proceeds to Benefit Alzheimer's Association
530p - Informal happy hour
6:00p - Comments by Stu Silberman, Senior Donor Advisor & Lisa Groon, Senior Director, Health Systems for Alzheimer's Association
Alzheimer’s disease is our nation’s largest under-recognized public health crisis. The lifetime risk for Alzheimer’s at age 45 is 1 in 5 for women, 1 in 10 for men.
More than 6 million Americans are living with Alzheimer’s today, and by 2050 this number is projected to increase to more than 12 million. A study published in The New England Journal of Medicine confirms that Alzheimer’s is the nation’s most expensive disease.
A new phase of Alzheimer’s therapy has begun. In January 2023, the U.S. Food and Drug Administration (FDA) approved Leqembi, which targets beta-amyloid protein “plaques,” a biomarker of the disease. Rigorous clinical trials show this drug can meaningfully change the course of the disease for those in the early stages.
The Alzheimer’s Association’s global research program explores many biological pathways of dementia, early detection, and methods for combining diverse approaches to treatment and prevention, including non-drug risk reduction strategies.
Come hear from a local Wharton alum and an expert from the Association about this condition and the state of research for detection, treatments, and prevention.
Stu Silberman is Senior Donor Advisor for the Alzheimer’s Association. Stu leads major gift fundraising for a six-state region where he helps families and family foundations craft plans that align their philanthropic interests with the Association’s mission areas.
Prior to joining the Association, Stu was CEO of two Jewish Federations: Minneapolis, Minnesota and Louisville, Kentucky, where he also ran a Jewish Community Center. Previously he served in leadership roles at UBS and Ford Motor Company.
Stu earned his B.S. in Computer Engineering from Lehigh University and MBA from the Wharton School of the University of Pennsylvania.
Lisa Groon is Senior Director, Health Systems for the Alzheimer’s Association. Lisa leads a team of professionals who work with large accounts to improve the quality of care for people with dementia through the implementation of evidence-based models and policy changes.
Lisa is also a Research Champion, where she conducts community sessions to educate attendees on the state of research and the work of the Alzheimer’s Association.
Lisa previously worked in a similar role at the American Cancer Society and was a policy advocate in South Dakota for the Alzheimer’s Association.
Lisa graduated from South Dakota State University with a degree in Human Development and Health Sciences. She has served as a Sergeant in the South Dakota Army National Guard for over 20 years.